Clinical trial
PRECISE-AFMR I: A Prospective Randomized Controlled Trial of Transcatheter Mitral Valve Edge-to-Edge Repair in Patients With Atrial Functional Mitral Regurgitation at High Surgical Risk
NCT07741253 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PRECISE-AFMR I: A Prospective Randomized Controlled Trial of Transcatheter Mitral Valve Edge-to-Edge Repair in Patients With Atrial Functional Mitral Regurgitation at High Surgical Risk
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 31, 2026
- Completion date
- December 31, 2027
- Enrollment
- 182 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial functional, mitral regurgitation (mr)